Search
for
Sort by
Research 811–840 of 1000+
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey
- BH03: Systemic sclerosis and frontal fibrosing alopecia: a novel combination of scarring alopecia
- Retrospektive Analyse von Wirksamkeit, Sicherheit, prognostischen Parametern und Faktoren der Lebensqualität bei der topischen Immuntherapie der Alopecia areata mit Diphenylcyclopropenon
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- Female hair loss
- Hair Loss in Children
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- Innervated Biomaterials for Improved Cutaneous Wound Healing: A Review of Recent Advancements and Future Prospects
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Application and progress of induced pluripotent stem in chronic wound healing: a narrative review
- A genomic approach to susceptibility and pathogenesis leads to identifying potential novel therapeutic targets in androgenetic alopecia
- Anti-oxidant and Anti-inflammatory Effects of Sinapic Acid in UVB Irradiation-Damaged HaCaT Keratinocytes
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- <i>N</i>1-acetylspermidine is a determinant of hair follicle stem cell fate
- Epidermal-Derived Hedgehog Signaling Drives Mesenchymal Proliferation during Digit Tip Regeneration
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy